EDP Sciences logo
Web of Conferences logo
Search
Menu
All issues Volume 292 (2021) E3S Web Conf., 292 (2021) 03095 References
Open Access
Issue
E3S Web Conf.
Volume 292, 2021
2021 2nd International Conference on New Energy Technology and Industrial Development (NETID 2021)
Article Number 03095
Number of page(s) 5
Section Environmental Sustainable Development and Industrial Transformation
DOI https://doi.org/10.1051/e3sconf/202129203095
Published online 09 September 2021
  1. El-Zayadi, A., et al., Impact of cigarette smoking on response to interferon therapy in chronic hepatitis C Egyptian patients. World J Gastroenterol, 2004. 10(20): p. 2963-6. [PubMed] [Google Scholar]
  2. McNab, F., et al., Type I interferons in infectious disease. Nat Rev Immunol, 2015. 15(2): p. 87-103. [CrossRef] [PubMed] [Google Scholar]
  3. Pestka, S., C.D. Krause, and M.R. Walter, Interferons, interferon-like cytokines, and their receptors. Immunol Rev, 2004. 202: p. 8-32. [CrossRef] [PubMed] [Google Scholar]
  4. Devaraj, S.G., et al., Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus. J Biol Chem, 2007. 282(44): p. 32208-21. [PubMed] [Google Scholar]
  5. Kopecky-Bromberg, S.A., et al., Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J Virol, 2007. 81(2): p. 548-57. [PubMed] [Google Scholar]
  6. Yang, Y., et al., The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists. Protein Cell, 2013. 4(12): p. 951-61. [PubMed] [Google Scholar]
  7. Channappanavar, R., et al., IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes. J Clin Invest, 2019. 129(9): p. 3625-3639. [PubMed] [Google Scholar]
  8. Blanco-Melo, D., et al., Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19. Cell, 2020. 181(5): p. 1036-1045.e9. [CrossRef] [PubMed] [Google Scholar]
  9. HuangFu, W.C., et al., Cigarette smoking products suppress anti-viral effects of Type I interferon via phosphorylation-dependent downregulation of its receptor. FEBS Lett, 2008. 582(21-22): p. 3206-10. [PubMed] [Google Scholar]
  10. Zheng, H., et al., Tyrosine phosphorylation of protein kinase D2 mediates ligand-inducible elimination of the Type 1 interferon receptor. J Biol Chem, 2011. 286(41): p. 35733-35741. [PubMed] [Google Scholar]
  11. Yao, Y., et al., Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus. Arthritis Rheum, 2009. 60(6): p. 1785-96. [PubMed] [Google Scholar]
  12. Benowitz, N.L., J. Hukkanen, and P. Jacob, 3rd, Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol, 2009(192): p. 29-60. [Google Scholar]
  13. Lammers, T., et al., Dexamethasone nanomedicines for COVID-19. Nat Nanotechnol, 2020. 15(8): p. 622-624. [PubMed] [Google Scholar]
  14. Soury, B., et al., Induction of interferon-beta gene expression by dexamethasone in murine L929 cells. Mol Endocrinol, 1995. 9(2): p. 199-207. [PubMed] [Google Scholar]
  15. Feng, Z., et al., Fludarabine inhibits STAT1-mediated up-regulation of caspase-3 expression in dexamethasone-induced osteoblasts apoptosis and slows the progression of steroid-induced avascular necrosis of the femoral head in rats. Apoptosis, 2017. 22(8): p. 1001-1012. [PubMed] [Google Scholar]
  16. Park, A. and A. Iwasaki, Type I and Type III Interferons -Induction, Signaling, Evasion, and Application to Combat COVID-19. Cell Host Microbe, 2020. 27(6): p. 870-878. [PubMed] [Google Scholar]
  17. Zhang, H., et al., Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med, 2020. 46(4): p. 586-590. [PubMed] [Google Scholar]
  18. Oakes, J.M., et al., Nicotine and the renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol, 2018. 315(5): p. R895-r906. [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.